Genetic Signatures Limited (ASX:GSS)
Australia · Delayed Price · Currency is AUD 0.1400
-0.0150 (-9.68%)
Apr 28, 2026, 4:10 PM AEST
Genetic Signatures Market Cap
Genetic Signatures has a market cap or net worth of 31.8 million as of April 28, 2026. Its market cap has decreased by -74.07% in one year.
Market Cap
31.80M
Enterprise Value
2.49M
Revenue
19.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since March 31, 2015, Genetic Signatures's market cap has decreased from 35.38M to 31.80M, a decrease of -10.11%. That is a compound annual growth rate of -0.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 35.21M | -38.00% |
| Dec 31, 2025 | 56.79M | -60.32% |
| Dec 31, 2024 | 143.10M | 99.47% |
| Dec 29, 2023 | 71.74M | -43.15% |
| Dec 30, 2022 | 126.20M | -50.73% |
| Dec 31, 2021 | 256.15M | -10.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Integral Diagnostics | 830.65M |
| Healius | 388.48M |
| Australian Clinical Labs | 362.15M |
| Monash IVF Group | 284.43M |
| Rhythm Biosciences | 58.39M |
| Cryosite | 51.25M |
| INOVIQ | 45.05M |
| Microba Life Sciences | 44.15M |